In the four cancer types (KIRC, KIRP, OV and UCS) in which higher expression levels of TP53 are associated with significantly worse OS or DFS prognoses, TP53 only shows significantly different expression in TP53-wildtype cancers (where it is higher) compared to TP53-mutated cancers in KIRK. The gene discussed is TP53; the disease is cancer.